Radiology Partners — FDA Petition for Imaging AI Regulatory Clarity
ENTITYRadiology Partners has formally petitioned the FDA seeking greater clarity around imaging AI regulations. The petition reflects frustration within the radiology community about the lack of clear regulatory standards governing how AI-assisted imaging tools should be cleared, deployed, and monitored in clinical settings. The petition comes amid growing evidence of regulatory inadequacy: multiple analyses have found that fewer than 1% of FDA-cleared AI medical devices have been tested on patient outcomes, and the existing clearance pathways were not designed with continuously-learning AI systems in mind. Radiology is one of the largest categories of FDA-cleared AI devices, making regulatory clarity particularly consequential for the specialty. Radiology Partners' petition joins a broader industry push — including from health systems, AI vendors, and clinical societies — for the FDA to develop clearer, more fit-for-purpose regulatory frameworks for AI medical devices. The petition is expected to inform the FDA's forthcoming guidance on both adaptive AI devices and generative AI in medical applications. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.